Squarepoint’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.74M	Sell	319,804 -124,223	-28%	-$1.82M	0.01%	1549
2025 Q4	$7.08M	Sell	444,027 -111,670	-20%	-$1.58M	0.01%	1246
2025 Q3	$6.14M	Buy	555,697 +71,760	+15%	+$784K	0.01%	1339
2025 Q2	$4.1M	Buy	483,937 +320,124	+195%	+$2.57M	﹤0.01%	1597
2025 Q1	$1.32M	Buy	163,813 +47,216	+40%	+$383K	﹤0.01%	2427
2024 Q4	$1.05M	Buy	+116,597	New	+$951K	﹤0.01%	3027
2023 Q3	–	Sell	-22,941	Closed	-$222K	–	3769
2023 Q2	$222K	Buy	22,941 +3,545	+18%	+$36.8K	﹤0.01%	3149
2023 Q1	$213K	Sell	19,396 -20,267	-51%	-$179K	﹤0.01%	2770
2022 Q4	$171K	Buy	39,663 +4,667	+13%	+$27.1K	﹤0.01%	2835
2022 Q3	$263K	Buy	+34,996	New	+$303K	﹤0.01%	2553
2022 Q2	–	Sell	-227,114	Closed	-$2.81M	–	2867
2022 Q1	$2.81M	Buy	227,114 +134,933	+146%	+$2.09M	0.01%	952
2021 Q4	$2.11M	Buy	92,181 +46,428	+101%	+$1.1M	0.01%	1227
2021 Q3	$1.01M	Buy	+45,753	New	+$726K	﹤0.01%	1554
2020 Q2	–	Sell	-35,084	Closed	-$509K	–	2220
2020 Q1	$509K	Buy	35,084 +5,989	+21%	+$106K	0.01%	1029
2019 Q4	$589K	Buy	+29,095	New	+$268K	﹤0.01%	1669